Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: IM-862 in Treating Patients With Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating IM-862 in patients with recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
A completed clinical trial comparing epidural analgesia versus patient-controlled analgesia for gynecologic cancer surgery, with conditions …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors [Phase 1]
A completed Phase 1 study evaluating the safety and tolerability of U3-1565 in patients with advanced solid tumors and advanced ovarian canc…
-
FDA approval · 2014-05-15FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Docetaxel (Sanofi-Aventis U.S. LLC), indicating an approved modification to its labeling and…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with recurrent or metastatic ovarian epithelial cancer, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer [Phase 2]
Phase 2 trial comparing weekly topotecan to a day 1-5 dosing schedule in platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety, efficacy, and pharmacokinetic study of siltuximab in patients with various solid tumors has been completed, including ov…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Globo H-KLH immunotherapy in women with non-progressive ovarian cancer; the current status of the study is not repo…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Guilford Genomic Medicine Initiative (GGMI)
The Guilford Genomic Medicine Initiative trial has completed (status: COMPLETED). The conditions listed for the study include breast cancer,…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancre…
-
EMA approval · 2014-03-21EMA recommends approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic
EMA recommends approval of a new treatment for platinum-resistant ovarian cancer, coordinated with a companion diagnostic to identify eligib…
-
FDA approval · 2014-02-28FDA Approved: HYCAMTIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Hycamtin (topotecan hydrochloride) from Novartis Pharmaceuticals Corporation. The action likely …
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [Phase 1]
Phase 1 study evaluating AFP464 in patients with metastatic or unresectable solid tumors completed; the trial enrolled patients with various…
-
CLINICAL_TRIALS research · 2014-02-20Clinical Trial Update: Blood Test for Ovarian Cancer Associated Auto Antibodies
A clinical trial update on a blood test by Eventus Diagnostics Ltd to detect autoantibodies associated with ovarian cancer; current status i…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium for ovarian cancer and primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in combination with carboplatin for recurrent ovarian epithelial cancer or primary peritoneal cancer; the…
-
CLINICAL_TRIALS research · 2014-02-14Clinical Trial Update: Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
This clinical trial update describes strategies being developed to increase enrollment of pediatric cancer patients in clinical trials.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer [Phase 2]
A Phase 2 study evaluating topotecan with erlotinib in topotecan-pretreated ovarian cancer was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse [Phase 3]
Phase 3 trial comparing Caelyx (liposomal doxorubicin) plus carboplatin with paclitaxel plus carboplatin in late-relapsed epithelial ovarian…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in pl…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating a chemo-immunotherapy regimen of gemcitabine, interferon-alpha 2b, and p53 SLP in platinum-resistant recurrent …
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update covers a phase 1/2 study of combination chemotherapy with peripheral stem cell transplantation for recurrent or p…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 clinical trial update describes a study of docetaxel plus carboplatin for patients with Stage III or IV ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]
This update covers a Phase 2 trial of temozolomide in advanced soft tissue sarcoma. The trial listing also notes related conditions of endom…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer [Phase 2]
Phase II study evaluating the combination of docetaxel and carboplatin in late-relapse ovarian cancer has been completed.